Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/5/2009

------- Total current assets 98,817,405 50,042,616 Property and equipment, net 6,826,161 4,477,020 Restricted cash 189,738 537,586 Other assets 25,082 90,792 ------ ------ Total assets $105,858,386 $55,148,014 ============ =========== Liabilities and Stockholders' Equity Current liabilities: Accounts payable 2,997,956 $4,877,854 Accrued liabilities 5,599,841 9,063,310 Current portion of long-term debt 6,229,049 7,694,173 Other current liabilities 22,048 22,048 ------ ------ Total current liabilities 14,848,894 21,657,385 Deferred rent 725,625 952,274 Long-term debt, less current portion and discount 1,650,996 6,098,113 Total stockholders' equity 88,632,871 26,440,242 ---------- ---------- Total liabilities and stockholders' equity $105,858,386 $55,148,014 ============ ===========

SOURCE Cadence Pharmaceuticals, Inc.


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
3. Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
4. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
8. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
9. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
11. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Cokato, MN (PRWEB) , ... August 31, 2015 , ... ... Hallmark series line of saunas. Available starting in the 3rd quarter, the newly re-styled ... that assembles quickly without special tools. , These new models include more glass and ...
(Date:8/31/2015)... ... August 31, 2015 , ... Physicians’ Education Resource®, LLC ... Symposium: Innovative Cancer Therapy for Tomorrow® meeting, is seeking abstract submissions for ... York City. The annual legacy meeting uses a variety of formats to educate ...
(Date:8/31/2015)... Louisville, KY (PRWEB) , ... August 31, 2015 ... ... Casper, Wyoming, has selected ezDI’s computer-assisted coding (CAC) software for its Clinical Documentation ... (NLP) engine, ezNLP, and a patent pending ICD-10 solution - ezCAC is an ...
(Date:8/31/2015)... ... August 31, 2015 , ... People with ... a greater risk for injury, potentially because they are more susceptible to the ... School of Public Health analysis discovered. , The research, published online in ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... users to develop skills and assess their competencies in managing challenging conversations, announced ... present at the Defense Centers of Excellence for Psychological Health and Traumatic ...
Breaking Medicine News(10 mins):Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 2Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 3Health News:Physicians’ Education Resource® Seeks Abstracts for the Upcoming Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® 4Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2
... Medical Plan with Health Savings Accounts and Supplemental Coverage ... The Guardian Life Insurance Company of ... life insurers and a leading provider of employee benefits ... offering a comprehensive, high-deductible healthcare plan that helps employers ...
... will help oncologists guide treatment of patients with ... Biodesix, Inc. today announces U.S. commercial availability of ... with advanced stage non-small cell lung cancer (NSCLC). ... good or poor outcomes following treatment with epidermal ...
... Palin Will Take Part in a Town Hall Meeting ... Teen PregnancyNEW YORK, May 5 The Candie,s Foundation ... its Teen Ambassador. Palin, daughter of Governor Sarah Palin ... and select media interviews to promote May 6th, the ...
... CDC also points to encouraging developments in Mexico, thought to ... News) -- The number of confirmed swine flu cases in ... But, the revised numbers indicate catching up on a backlog ... infections, federal health officials said. , And, while insisting that ...
... Calif., May 5 The recession has forced many ... leaves concerned moms across the U.S. asking, "How will ... children isn,t so much about the quantity of time ... quality," says Dr. Robert Puff, a clinical psychologist based ...
... Automated Hemostasis Analyzer with Chemiluminescent Technology - , BEDFORD, ... that it has received FDA clearance 510(k) for the ... IL to market the ACL AcuStar Hemostasis Testing System, ... The ACL AcuStar is the first specialty-test analyzer that ...
Cached Medicine News:Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 2Health News:Guardian Launches Comprehensive, Consumer-Driven Healthcare Program 3Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 2Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 3Health News:The Candie's Foundation Appoints Bristol Palin As Teen Ambassador 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 2Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 3Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 4Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 5Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 6Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 7Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 8Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 9Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 10Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 11Health News:While Swine Flu Cases Are Still Rising, U.S. Officials See Hopeful Signs 12Health News:Mother's Day Blues: When Being a Stay-at-Home Mom Is No Longer an Option 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 2Health News:Instrumentation Laboratory Launches ACL AcuStar(TM) Hemostasis Testing System 3
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
(Date:8/31/2015)... , Aug. 31, 2015 Thousands of people ... neglect of the opioid addiction epidemic at dozens of ... term in 2008, the United States ... addiction involving prescription opioids and heroin, yet the President ... a strongly worded letter to President Obama , ...
(Date:8/31/2015)... , August 31, 2015 ... the global cardiovascular monitoring and diagnostic devices market ... predicted to reach a value of approximately US$7.0 ... 9.7% between 2013 and 2019. The title of ... Market (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: